ELV Elevance Health, Inc.
AI brief AI-written, not reviewed by a person
Latest available figures show cash and equivalents at 10,348,000,000 as of 2026-09-30, with stockholders’ equity around 44,681,000,000 and total assets about 127,801,000,000; diluted EPS for 12 months to 2025-12-31 is 25.21 USD, while for 3 months ended 2026-09-30 diluted EPS is 6.27 USD, and quarterly revenue for the quarter ended 2026-09-30 is 51,429,000,000. These figures are sourced from SEC 10-Q/filings covering periods up to 2026-09-30, with corresponding prior periods shown for year-over-year or sequential comparisons where provided in the same sources.
- Cash and equivalents rose from 9,471,000,000 (2025-12-31) to 10,348,000,000 (2026-09-30). [1]
- Diluted EPS (year) for 12 months to 2025-12-31 is 25.21 USD; 12 months to 2024-12-31 is 25.68 USD. [1]
- 3-month diluted EPS for 2026-09-30 is 6.27 USD; for 2026-06-30 is 6.71 USD; for 2026-03-31 is 8.00 USD. [1]
- Stockholders’ equity at 2026-09-30 is 44,681,000,000 USD; at 2026-06-30 is 44,883,000,000 USD. [1]
- Long-term debt at 2026-09-30 is 30,382,000,000 USD; at 2026-06-30 is 30,669,000,000 USD. [1]
- Net income (year) for 12 months to 2025-12-31 is 5,662,000,000 USD. [1]
- Net income (quarter) for 3 months to 2026-09-30 is 1,365,000,000 USD. [1]
- Operating cash flow (year) for 12 months to 2025-12-31 is 4,290,000,000 USD. [1]
- Operating income (year) for 12 months to 2025-12-31 is 7,199,000,000 USD. [1]
- Revenue (year) for 12 months to 2025-12-31 is 199,125,000,000 USD. [1]
- Revenue (quarter) for 3 months to 2026-09-30 is 51,429,000,000 USD. [1]
- Shares outstanding at 2026-10-15 are 216,055,891. [1]
- Total assets at 2026-09-30 are 127,801,000,000 USD; total liabilities at 2026-09-30 are 83,007,000,000 USD. [1][2]
Written by OpenVibe.AI from the SEC numbers and filings on this page, not reviewed by a person. Informational only; not investment advice. Written from figures and filings up to (gpt-5-nano-2025-08-07).
Observations
| Metric | Value | Observed | Source | Retrieved | Freshness |
|---|---|---|---|---|---|
| Revenue (quarter) (3 months to 2026-09-30) | 51,429,000,000 USD | sec-companyfacts | current | ||
| Revenue (year) (12 months to 2025-12-31) | 199,125,000,000 USD | sec-companyfacts | current | ||
| Net income (quarter) (3 months to 2026-09-30) | 1,365,000,000 USD | sec-companyfacts | current | ||
| Net income (year) (12 months to 2025-12-31) | 5,662,000,000 USD | sec-companyfacts | current | ||
| Operating income (quarter) (3 months to 2026-09-30) | 1,269,000,000 USD | sec-companyfacts | current | ||
| Operating income (year) (12 months to 2025-12-31) | 7,199,000,000 USD | sec-companyfacts | current | ||
| Diluted EPS (quarter) (3 months to 2026-09-30) | 6.27 USD/shares | sec-companyfacts | current | ||
| Diluted EPS (year) (12 months to 2025-12-31) | 25.21 USD/shares | sec-companyfacts | current | ||
| Operating cash flow (quarter) (3 months to 2026-03-31) | 4,332,000,000 USD | sec-companyfacts | current | ||
| Operating cash flow (year) (12 months to 2025-12-31) | 4,290,000,000 USD | sec-companyfacts | current | ||
| Total assets (at 2026-09-30) | 127,801,000,000 USD | sec-companyfacts | current | ||
| Total liabilities (at 2026-09-30) | 83,007,000,000 USD | sec-companyfacts | current | ||
| Stockholders' equity (at 2026-09-30) | 44,681,000,000 USD | sec-companyfacts | current | ||
| Cash and equivalents (at 2026-09-30) | 10,348,000,000 USD | sec-companyfacts | current | ||
| Long-term debt (at 2026-09-30) | 30,382,000,000 USD | sec-companyfacts | current | ||
| Shares outstanding (at 2026-10-15) | 216,055,891 shares | sec-companyfacts | current |
Context
No reviewed context has been published for ELV. The observations and documents below are shown as their sources stated them.
Documents
Source freshness
| Source | Freshness | Last successful fetch | Stale after | Sources reports |
|---|---|---|---|---|
| SEC EDGAR: company financial facts (XBRL) sec-companyfacts | current | 10080 min | ok | |
| SEC EDGAR: latest XBRL filings sec-xbrl-filings | current | 45 min | healthy |
Watch this instrument
Sign in to add ELV to a private watchlist or to get an alert when a new document or observation arrives.
Machine-readable: ELV.json (the same data with every timestamp and source).
Information only — not investment advice; no trading here. OpenVibe.Trade holds no money or assets, takes no orders and gives no personal recommendations.